Daniel Woo
Medical Practice at Piedmont Ave, Cincinnati, OH
License number
Kentucky 34582
Issued Date
Dec 17, 1998
Expiration Date
Feb 28, 2018
Category
Neurology
Type
Hospital Based
Address
Address
222 Piedmont Ave SUITE 3200, Cincinnati, OH 45219
Education
University of Cincinnati College of Medicine, 1994
Phone
(513) 558-5478 (Work)
Personal information
See more information about Daniel Woo at radaris.comName
Address
Phone
8355 Miami Rd, Cincinnati, OH 45243
9125 Kugler Mill Rd, Cincinnati, OH 45243
1042 Zebulon Ave, Columbus, OH 43224
9125 Kugler Mill Rd, Cincinnati, OH 45243
8355 Miami Ave, Kenwood, OH 45243
Organization information
See more information about Daniel Woo at bizstanding.comUniversity Neurology Inc - Daniel Woo MD
222 Piedmont Ave STE 3200, Cincinnati, OH 45219
Categories:
Neurology Physicians & Surgeons, Physicians & Surgeons
Phone:
(513) 475-8730 (Phone)
Professional information
See more information about Daniel Woo at trustoria.com
Dr. Daniel Woo, Cincinnati OH - MD (Doctor of Medicine)
Dr. Daniel Woo, Cincinnati OH - MD (Doctor of Medicine)
Specialties:
Vascular Neurology
Address:
UC Physicians Neurology
222 Piedmont Ave SUITE 3200, Cincinnati 45219
(513) 475-8730 (Phone)
222 Piedmont Ave SUITE 3200, Cincinnati 45219
(513) 475-8730 (Phone)
Procedures:
EEG (Electroencephalogram)
Conditions:
Ataxia, Bell's Palsy, Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma), Carotid Artery Disease, Cerebral Aneurysm, Cerebral Artery Thrombosis, Cerebral Vascular Disease, Cerebrovascular Disease, Cluster Headache, Concussion, Convulsions, Diplopia, Dystonia, Epilepsy, Essential Tremor, Gait Abnormality, Headache, Huntington's Disease, Hydrocephalus, Inflammatory and Toxic Neuropathy, Migraine, Multiple Sclerosis (MS), Myasthenia Gravis, Parkinson's Disease, Peripheral Nerve Disorders, Polymyositis, Post-Concussion Syndrome, Radiculopathy (not Due to Disc Displacement), Rasmussen's Syndrome, Sleep Apnea, Stroke, Syncope, Transient Ischemic Attack (TIA), Tremor, Trigeminal Neuralgia, Vertigo
Certifications:
Neurology, 2009, Vascular Neurology, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UC Physicians Neurology
222 Piedmont Ave SUITE 3200, Cincinnati 45219
University Hospital
234 Goodman St, Cincinnati 45219
222 Piedmont Ave SUITE 3200, Cincinnati 45219
University Hospital
234 Goodman St, Cincinnati 45219
Education:
Medical School
University Of Cincinnati College Of Medicine
Graduated: 1994
Cleveland Clinic Fndn
University Of Cincinnati College Of Medicine
Graduated: 1994
Cleveland Clinic Fndn
Daniel Woo, Cincinnati OH
Daniel Woo, Cincinnati OH
Work:
University of Cincinnati
222 Piedmont Ave, Cincinnati, OH 45219 University Hospital, Inc
234 Goodman St, Cincinnati, OH 45219
222 Piedmont Ave, Cincinnati, OH 45219 University Hospital, Inc
234 Goodman St, Cincinnati, OH 45219
Methods For Enhancing The Lysis Of Coagulated Blood With Apolipoprotein E2 Phenotype
Methods For Enhancing The Lysis Of Coagulated Blood With Apolipoprotein E2 Phenotype
US Patent:
7208288, Apr 24, 2007
Filed:
Oct 12, 2001
Appl. No.:
10/398880
Inventors:
Joseph P. Broderick - Cincinnati OH, US
Joseph F. Clark - Cincinnati OH, US
Daniel Woo - Cincinnati OH, US
Joseph F. Clark - Cincinnati OH, US
Daniel Woo - Cincinnati OH, US
International Classification:
C12Q 1/56
US Classification:
435 13, 424 9464, 436 69, 514 2, 514 21, 514822, 53036825
Abstract:
Methods for enhancing the lysis of coagulated blood comprise administering to coagulated blood a combination of clot clysis agent and a lysis enhancing amount of apolipoprotein E2 (Apo E2) or a therapeutic derivative thereof. Methods for reducing the risk of blood coagulation comprise administering to blood a combination of a clot lysis agent and a lysis enhancing amount of Apo E2 or a therapeutic derivative thereof. Additional methods for enhancing the lysis of coagulated blood comprise administering to an individual a specific level of clot lysis agent wherein the specific level is based upon the apolipoprotein phenotype of the individual. Further methods for reducing the risks of blood coagulation comprise administering to blood a specific level of a clot lysis agent wherein the specific level is based upon the apolipoprotein phenotype of the individual.
Methods For Controlling The Lysis Of Coagulated Blood With Apolipoprotein E4 Phenotype
Methods For Controlling The Lysis Of Coagulated Blood With Apolipoprotein E4 Phenotype
US Patent:
7135305, Nov 14, 2006
Filed:
Oct 12, 2001
Appl. No.:
10/398882
Inventors:
Joseph P. Broderick - Cincinnati OH, US
Joseph F. Clark - Cincinnati OH, US
Daniel Woo - Cincinnati OH, US
Joseph F. Clark - Cincinnati OH, US
Daniel Woo - Cincinnati OH, US
International Classification:
C12Q 1/56
US Classification:
435 13, 424 9464, 53036825
Abstract:
Methods for inhibiting lysis of coagulated blood and reducing risk of excessive lysis comprising administration of lysis-inhibiting amounts of apolipoprotein E4, and methods for inhibiting lysis of coagulated blood and reducing risk of excessive lysis comprising administration of a specific level of a lysis-inhibiting agent wherein the specific level is based on the apolipoprotein phenotype of an individual, are provided. Methods for enhancing lysis of coagulated blood by administration of an Apo E peptide fragment to blood containing a clot lysis agent are also provided.